Skip to main content

Table 5 Skeletal and dental treatment effects in the facemask group

From: Early Class III treatment with Hybrid-Hyrax -Facemask in comparison to Hybrid-Hyrax-Mentoplate – skeletal and dental outcomes

Variables Facemask T0 Facemask T1 p values CI 95%  
SNA° 79.41 ± 2.86 81.66 ± 2.92 0.000* 1.60 2.90
SNB° 80.51 ± 3.26 79.02 ± 3.27 0.000* − 2.06 − 0.91
ANB° − 1.10 ± 1.98 2.65 ± 2.34 0.000* 3.00 4.49
WITS mm − 5.39 ± 1.47 − 0.57 ± 1.51 0.000* 4.02 5.52
ATV mm 59.99 ± 2.99 62.42 ± 3.47 0.000* 1.71 3.13
BTV mm 59.32 ± 4.78 57.52 ± 5.05 0.002* − 2.81 − 0.74
ABTV mm 0.67 ± 3.16 4.90 ± 3.60 0.000* 3.30 5.14
ML-NL° 26.06 ± 5.44 27.95 ± 6.12 0.000* 1.03 2.74
ML-NSL° 32.65 ± 6.27 33.79 ± 6.11 0.149 0.37 1.90
NSL-NL° 6.58 ± 2.93 5.84 ± 3.96 0.148 (W) − 0.27 1.76
AR-GO-ME° 126.92 ± 7.05 127.33 ± 6.92 0.001* 0.19 0.61
MOK-A mm 26.37 ± 2.21 26.30 ± 2.19 0.246 − 0.05 0.19
U1-PP° 108.19 ± 7.85 107.04 ± 6.92 0.473 − 2.16 4.47
L1-ML° 86.87 ± 6.27 83.04 ± 4.26 0.028* (W) − 6.99 − 0.67
  1. W Wilcoxon
  2. *significant at p < 0.05